Current report filing

Condensed Consolidated Interim Statement of Loss and Comprehensive Loss (Unaudited)

v3.19.1
Condensed Consolidated Interim Statement of Loss and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenue
Expenses:        
Research and development 3,591 1,390 14,549 4,213
General and administrative 2,020 1,319 8,233 4,302
Operating Expenses 5,611 2,709 22,782 8,515
Other income (expense):        
Interest income 80 69 198 142
Foreign exchange gains (losses) (23)
Total other income 80 69 175 142
Net loss (5,531) (2,640) (22,607) (8,373)
Other comprehensive loss        
Foreign currency translation gain (loss)
Unrealized gain on securities available-for-sale 9 3
Total comprehensive loss $ (5,522) $ (2,640) $ (22,604) $ (8,373)
Basic and diluted loss per common share (in dollars per share) $ (0.16) $ (0.11) $ (0.71) $ (0.40)
Weighted average number of common shares outstanding used in the calculation of basic and diluted loss per common share (000’s) (in shares) 34,587 24,061 32,039 20,954